Search Results - "Fuster Salvà, José"

TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck by Rubió-Casadevall, Jordi, Cirauqui Cirauqui, Beatriz, Martinez Trufero, Javier, Plana Serrahima, Maria, García Castaño, Almudena, Carral Maseda, Alberto, Iglesias Docampo, Lara, Pérez Segura, Pedro, Ceballos Lenza, Isaac, Gutiérrez Calderón, Vanesa, Fuster Salvà, José, Pena Álvarez, Carolina, Hernandez, Irene, del Barco Morillo, Edel, Chaves Conde, Manuel, Martínez Galán, Joaquina, Durán Sánchez, Marisa, Quiroga, Vanesa, Ortega, Eugenia, Mesia, Ricard

“…ObjectivesThe aim of this study was to confirm the efficacy of the ERBITAX scheme (paclitaxel 80 mg/m2 weekly and cetuximab 400 mg/m2 loading dose, and then…”
Get full text

Extraosseous Ewing Sarcoma: Expanding the Differential Diagnosis of Supraclavicular Fossa Tumors by Rama-López, Julio, Asensio, Rafael Ramos, García-Garza, Cesar, Fra, Pablo Luna, Balaguer, Maria del Carmen Gassent, Salva, Jos& Fuster

“…A broad spectrum of diseases can be included in the differential diagnosis of neck masses. We report a case of extraosseous Ewing sarcoma that presented as a…”
Get full text

Extraosseous Ewing sarcoma: expanding the differential diagnosis of supraclavicular fossa tumors by Rama-Lopez, Julio, Asensio, Rafael Ramos, Garcia-Garza, Cesar, Fra, Pablo Luna, Balaguer, Maria del Carmen Gassent, Salva, Jose Fuster

Get full text